Translational progress on tumor biomarkers

There is an urgent need to apply basic research achievements to the clinic. In particular, mechanistic studies should be developed by bench researchers, depending upon clinical demands, in order to improve the survival and quality of life of cancer patients. To date, translational medicine has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Hongwei, Zhou, Xiaolin, Lu, Yi, Xie, Liye, Chen, Qian, Keller, Evan T, Liu, Qian, Zhou, Qinghua, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632916/
https://www.ncbi.nlm.nih.gov/pubmed/26557902
http://dx.doi.org/10.1111/1759-7714.12294
Descripción
Sumario:There is an urgent need to apply basic research achievements to the clinic. In particular, mechanistic studies should be developed by bench researchers, depending upon clinical demands, in order to improve the survival and quality of life of cancer patients. To date, translational medicine has been addressed in cancer biology, particularly in the identification and characterization of novel tumor biomarkers. This review focuses on the recent achievements and clinical application prospects in tumor biomarkers based on translational medicine.

Ejemplares similares